Antitumor effect of calmodulin antagonist against MH-134 hepatoma, Ehrlich ascites carcinoma and B-16 melanocarcinoma in mice.
D000818:Animals; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*
D002147:Calmodulin; D013449:Sulfonamides; C017967:W 7; C034700:N-(6-aminohexyl)-1-naphthalenesulfonamide